Elsevier Inc.

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Bajorin
    Bajorin
  4. Rosenberg
    Rosenberg
  5. Iyer
    Iyer
  6. Solit
    Solit
  7. Feldman
    Feldman
  8. Morris
    Morris
  9. Slovin
    Slovin
  10. Voss
    Voss

Groups

  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)
  7. Urology (54)
  8. Hematologic Malignancies, Division of (49)
  9. Human Oncology and Pathogenesis Program (49)
  10. Department of Pathology and Laboratory Medicine (46)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (245)
  2. Meeting Abstract (120)
  3. Review (7)
  4. Conference Paper (6)
  5. Book Section (3)
  6. Editorial (2)
  7. Guidelines (1)
Groups
  1. Genitourinary Oncology Service (384)
  2. Solid Tumor Oncology Division (384)
  3. Department of Medicine (383)
  4. GSK Faculty (92)
  5. Surgery (68)
  6. Survivorship Research (63)

More Groups

People
  1. Robert Motzer (89)
  2. Howard Scher (72)
  3. Dean Bajorin (50)
  4. Jonathan Rosenberg (39)
  5. David Solit (33)
  6. Gopakumar Iyer (33)

More People

Years
  1. 2025 (9)
  2. 2024 (31)
  3. 2023 (12)
  4. 2022 (18)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. European Journal of Cancer (96)
  2. Clinical Genitourinary Cancer (63)
  3. Urologic Oncology: Seminars and Original Investigations (49)
  4. International Journal of Radiation Oncology, Biology, Physics (47)
  5. Seminars in Oncology (41)
  6. Hematology/Oncology Clinics of North America (10)

More Publications

Results (384)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis
    Meeting Abstract

    Alekseev, B.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)
    Meeting Abstract

    Harshman, L.; Werner, L.; Wong, Y. N.; Yu, E.; Alva, A.; Crabb, S.; Powles, T.; Rosenberg, J.; Baniel, J.; Vaishampayan, U.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Predicting venous thromboembolism (VTE) in metastatic urothelial tract tumors (UTT)
    Meeting Abstract

    Ramos, J.; Casey, M.; Bamias, A.; De Giorgi, U.; Bellmunt, J.; Harshman, L.; Ladoire, S.; Wong, Y. N.; Alva, A.; Necchi, A.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Baseline characteristics, number of radium-223 (Ra-223) injections, and overall survival (OS) in US Expanded Access Program (EAP) and ALSYMPCA
    Meeting Abstract

    Sartor, O.; Coleman, R. E.; Morris, M. J.; Nilsson, S.; Shore, N.; Sweeney, C.; Vogelzang, N. J.; Petrenciuc, O.; Gratt, J.; Parker, C.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Early onset colorectal cancer - Does the difference lie in epigenetics?
    Meeting Abstract

    Ben-Aharon, I.; Pelossof, R.; Elkabets, M.; Battaglin, F.; Goodman, K.; Yaeger, R.; Saltz, L.; Schultz, N.; Solit, D.; Garcia-Aguilar, J.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial
    Meeting Abstract

    George, S.; Motzer, R. J.; Hammers, H.; Redman, B.; Kuzel, T.; Tykodi, S. S.; Plimack, E.; Jiang, J.; Waxman, I.; Rini, B. I.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Presence of AR-V7 splice variant or AR C terminal loss in the CTCs of mCRPC patients identifies patients with improved PSA response with taxanes over androgen receptor signaling directed therapies (ARS Rx)
    Meeting Abstract

    Scher, H. I.; Kelvin, J.; Lu, D.; Louw, J.; Packer, D.; Bambury, R.; Rathkopf, D.; Schreiber, N.; Brennan, R.; Prigozhina, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy
    Meeting Abstract

    Glen, H.; Hsieh, J.; Michaelson, M. D.; Kim, H. J.; Sachdev, P.; Kadowaki, T.; Funahashi, Y.; Larkin, J.; Motzer, R.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer
    Meeting Abstract

    Voss, M.; Gordon, M. S.; Mita, M.; Rini, B.; Makker, V.; Macarulla, T.; Smith, D.; Kwak, E. L.; Cervantes, A.; Puzanov, I.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Safety and anti-tumour activity of pegylated recombinant human IL-10 (Am0010) in selected advanced solid tumours
    Meeting Abstract

    Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Falchook, G.; Wong, D.; Whiteside, M.; Oft, M.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save